Anemia prognostic value in predicting recurrent acute myocardial infarction
Abstract
The aim of the study was to determine whether anemia is an independent predictor for recurrent myocardial infarction (MI), and to interpret the results obtained, using multiple statistics method - correlation analysis. In total, 171 patients (mean age 64, 2 ± 10 years) with acute MI were examined. All participants received thrombolytic therapy. Patients with bleeding in anamnesis or sever comorbidities were excluded from the study. Red blood cell and hemoglobin levels in capillary blood were measured at admission. The following parameters were registered: elderly age, heart failure class by Killip, coronary anamnesis duration, MI, stroke, diabetes mellitus, arterial hypertension, atrial fibrillation in anamnesis, left ventricular hypertrophy and dilatation at echocardiography. Mean follow-up period lasted for 21 days; post-MI angina and recurrent MI were registered. In multiple analysis, logistic regression and correlation analysis were performed. Post-MI angina without progression into recurrent MI was observed in 62 patients. Recurrent MI was registered in 19 participants; in this group, anemia was observed more often (47, 4 %) than in individuals without recurrent angina or MI(25 %; p = 0, 002). According to univariate analysis and logistic regression results, there was no significant correlation between anemic syndrome and post-MI angina. Anemia was an independent predictor of recurrent MI (p = 0, 03; odds ratio 3, 11; 95 % CI 1, 07-9, 0). Anemia prognostic role was confirmed by correlation analysis: patients with post-MI angina and recurrent MI substantially differed from each other, as well as from other patients, by baseline characteristics. Therefore, anemic syndrome could be regarded as an independent predictor of recurrent MI. Correlation analysis is effective in assessing multiple information on acute MI patients.

About the Authors
T. Yu. KaluytaRussian Federation
V. P. Tokarev
Russian Federation
R. N. Karimov
Russian Federation
Yu. G. Schwartz
Russian Federation
References
1. Арутюнов Г.П. Анемия у больных с ХСН. // Сердечная недостаточность. 2003. № 4. С. 224-228
2. Власов В.В. Введение в доказательную медицину. М.: Изд-во Медиа Сфера, 2001. 392 с.
3. Гланц С. Медико-биологическая статистика: Пер. с англ. М.: Практика, 1998. 460 с.
4. Калюта Т.Ю., Любезнов Р.Е., Орликова О.В. и др. Осложнения острого инфаркта миокарда и антитромботической терапии у больных с анемией//Кардиоваскулярная терапия и профилактика. 2003. № 5. С. 70-75.
5. Каримов Р.Н. Обработка экспериментальной информации. Саратов: Копипринтер, 2002. 113 с.
6. Митькова В.В. Клиническое руководство по ультразвуковой диагностике. М.: Изд-во Дидар, 1988. 360 с.
7. Сыркин А.Л. Инфаркт миокарда: 3-е изд., перераб. и доп. М.: Медицинское информационное агентство, 2003. 466 с.
8. Харрисон Р.Т. Внутренние болезни: Пер. с англ. М.: Практика, 2002. Т. 1. 1536 с.
9. Шиллер Н. Клиническая эхокардиография. М.: Изд-во Мир, 1993. 347 с.
10. АСС/АНА guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)/T.J. Ryan, E.M. Antman, N.H. Brooks et al.//Circulation. 1999. Vol. 100. P. 1016-1030.
11. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction/R.C. Becker, J.M. Gore, C. Lambrew et al.//J Am Coll Cardiol. 1996. Vol. 27. P. 1321-1326.
12. Moriel M., Benhorin J., Brown M.W. et al. Detection and significance of myocardial ischemia in women versus men within six months of acute muocardial infarction unstable angina. The Multicenter Myocardial Ishemia Research Group // Am. J. Cardiol. 1996. Vol. 77, N 10. P. 798-804.
13. Vreede J.J., Gorgels A.P., Verstraaten G.M. et al. Did prognosis after acute myocardial infarction change during the past 30 years?//J Am Coll Cardiol. 1991. Vol. 18, N 3. P. 698-706.
14. Mahon N.G., O'rorke C., Codd M.B. et al. Hospital mortality of acute myocardial infarction in the thrombolytic era//Heart. 1999. Vol. 81, N 5. P. 478-482.
15. Killip T., Kimball J.T. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients // Am J Cardiol. 1967. Vol. 20. P. 457-464.
16. Fullhaas J.U., Rickenbacher P., Pfisterer M. et al. Long-term prognosis of young patients after myocardial infarction in the thrombolytic era//Clin. Cardiol. 1997. Vol. 20, N 12. P. 993-998.
17. The Hirulog and Early Reperfusion or Occlusion (HERO-2) Trial Investigators/Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction//Lancet. 2001. Vol. 358. P. 1855-1863.
Review
For citations:
Kaluyta T.Yu., Tokarev V.P., Karimov R.N., Schwartz Yu.G. Anemia prognostic value in predicting recurrent acute myocardial infarction. Russian Journal of Cardiology. 2006;(1):58-62. (In Russ.)